How the reference values for serum parathyroid hormone concentration are (or should be) established?
- 372 Downloads
Well-validated reference values are necessary for a correct interpretation of a serum PTH concentration. Establishing PTH reference values needs recruiting a large reference population. Exclusion criteria for this population can be defined as any situation possibly inducing an increase or a decrease in PTH concentration. As recommended in the recent guidelines on the diagnosis and management of asymptomatic primary hyperparathyroidism, PTH reference values should be established in vitamin D-replete subjects with a normal renal function with possible stratification according to various factors such as age, gender, menopausal status, body mass index, and race. A consensus about analytical/pre-analytical aspects of PTH measurement is also needed with special emphasis on the nature of the sample (plasma or serum), the time and the fasting/non-fasting status of the blood sample. Our opinion is that blood sample for PTH measurement should be obtained in the morning after an overnight fast. Furthermore, despite longer stability of the PTH molecule in EDTA plasma, we prefer serum as it allows to measure calcium, a prerequisite for a correct interpretation of a PTH concentration, on the same sample. Once a consensus is reached, we believe an important international multicentre work should be performed to recruit a very extensive reference population of apparently healthy vitamin D-replete subjects with a normal renal function in order to establish the PTH normative data. Due to the huge inter-method variability in PTH measurement, a sufficient quantity of blood sample should be obtained to allow measurement with as many PTH kits as possible.
KeywordsParathyroid hormone (PTH) Vitamin D Reference values Primary hyperparathyroidism Chronic kidney disease
Compliance with ethical standards
Conflict of interest
JCS reports lecture fees and/or travel/hotel expenses from DiaSorin, Roche Diagnostics, Abbott, Amgen, Shire, MSD, Lilly, Rottapharm, Meda. EC is consultant for IDS and DiaSorin and has received lecture fees from IDS, DiaSorin, Roche, Abbott, and Amgen. SM served as a speaker for Abiogen, Amgen, Diasorin, Eli Lilly, Italfarmaco, Fujii, Merck Sharp and Dohme, Takeda. He also served in advisory board of Amgen and Eli Lilly. FB, MLP, and CC have nothing to declare.
Not applicable to this review article.
Not applicable to this review article.
- 5.Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C et al (1998) A non (1–84) circulating parathyroid hormone fragment interferes significantly with intact PTH commercial assay in uremic samples. Clin Chem 44:4287–4290Google Scholar
- 10.Touvier M, Deschasaux M, Montourcy M, Sutton A, Charnuax N, Kess-Guyot E et al (2014) Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. J Clin Endocrinol Metab 99:1196–1203CrossRefPubMedGoogle Scholar
- 12.Blind E, Schmidt-Gayk H, Scharla S, Flentje D, Fischer S, Göhring U et al (1988) Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a mid-region assay. J Clin Endocrinol Metab 67:353–360CrossRefPubMedGoogle Scholar
- 15.Gao P, Scheibel S, D’Amour P, John M, Rao S, Schmidt-Gayk H et al (2001) Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1–84: implication for improvement of accurate assessment of parathyroid function. J Bone Miner Res 16:605–614CrossRefPubMedGoogle Scholar
- 23.Cavalier E, Delanaye P, Vranken L, Bekaert AC, Carlisi A, Chapelle JP et al (2012) Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values. Nephrol Dial Transpl 27:1950–1956CrossRefGoogle Scholar
- 27.Souberbielle JC, Massart C, Brailly-Tabard S, Cormier C, Cavalier E, Delanaye P et al (2016) Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients. Eu J Endocrinol 174:315–323CrossRefGoogle Scholar
- 30.KDIGO C-M (2009) Work Group KDIGO Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone disorder (CKD-MBD). Kidney Int 76(Suppl 113):S1–130Google Scholar
- 34.Bailey D, Colantino D, Kuriakopoulou L, Cohen A, Chan MK, Armbruster D et al (2013) Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from CALIPER cohort. Clin Chem 59:1393–1405CrossRefPubMedGoogle Scholar
- 35.Soldin O, Dahlin J, Gresham E, King J, Soldin S (2008) Immulite 2000 age and sex-specific reference intervals for alpha fetoprotein, homocysteine, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein-3, C-peptide, immunoglobulin E and intact parathyroid hormone. Clin Biochem 41:937–942CrossRefPubMedPubMedCentralGoogle Scholar
- 42.Uemura H, Yasui T, Kiyokawa M, Kuwahara A, Ikawa H, Matsuzaki T et al (2002) Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers. J Endocrinol 174:353–359CrossRefPubMedGoogle Scholar
- 44.Fuleihan GEH, Klerman E, Brown E, Choe Y, Brown E, Czeisler C (1997) The parathyroid hormone circadian rhythm is truly endogenous—a general clinical research center study. J Clin Endocrinol Metab 82:281–286Google Scholar
- 45.Rejnmark L, Lauridsen A, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L (2002) Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to plasma parathyroid hormone and calcium and phosphate metabolism. Eur J Endocrinol 146:635–642CrossRefPubMedGoogle Scholar
- 46.Smith E, Cai M, McMahon L, Holt S (2012) Biological variability of plasma intact and C-terminal FGF23 measurements. J Clin Endocrinol Metab 97:3501–3504Google Scholar